Amgen Inc. (AMGN)

171.28
NASDAQ : Health Technology
Prev Close 172.11
Day Low/High 171.09 / 173.77
52 Wk Low/High 166.30 / 210.19
Avg Volume 2.87M
Exchange NASDAQ
Shares Outstanding 609.94M
Market Cap 104.98B
EPS 12.70
P/E Ratio 13.71
Div & Yield 5.80 (3.16%)

Latest News

Amgen Announces A Recommended Public Cash Offer To The Shareholders Of Nuevolution

Amgen Announces A Recommended Public Cash Offer To The Shareholders Of Nuevolution

THOUSAND OAKS, Calif., May 21, 2019 /PRNewswire/ -- The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, Australia,...

Amgen Announces Voting Results Of Annual Meeting Of Stockholders

Amgen Announces Voting Results Of Annual Meeting Of Stockholders

THOUSAND OAKS, Calif., May 21, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced voting results from the Company's Annual Meeting of Stockholders, held in Westlake Village, Calif.

Weekly Roundup

Markets' rocky week ends up close to where it began.

Bulls Make Money, Bears Make Money and Hogs Get Slaughtered, Jim Cramer Says

Bulls Make Money, Bears Make Money and Hogs Get Slaughtered, Jim Cramer Says

That's Rule No. 5 of his '5 Rules for Trimming Your Winning Positions.'

China Winners and Losers: Cramer's 'Mad Money' Recap (Thursday 5/16/19)

China Winners and Losers: Cramer's 'Mad Money' Recap (Thursday 5/16/19)

Jim Cramer says Thursday's market action showed us a rally based on good old-fashioned earnings.

Palo Alto Networks, Ulta Beauty, CarGurus: 'Mad Money' Lightning Round

Palo Alto Networks, Ulta Beauty, CarGurus: 'Mad Money' Lightning Round

Jim Cramer looks at Palo Alto Networks, Ulta Beauty, CarGurus, TradeWeb Markets, Amgen, Marathon Oil.

Amgen To Present At The RBC Healthcare Conference And The UBS Global Healthcare Conference

Amgen To Present At The RBC Healthcare Conference And The UBS Global Healthcare Conference

THOUSAND OAKS, Calif., May 16, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the RBC Health Care Conference at 8:30 a.

Amgen Showcases Oncology Pipeline At ASCO 2019

Amgen Showcases Oncology Pipeline At ASCO 2019

Data From Largest Oncology Pipeline in Company's History

Sell Part of a Winning Stock If Trouble Hits Others in Its Sector, Cramer Says

Sell Part of a Winning Stock If Trouble Hits Others in Its Sector, Cramer Says

Rule No. 3 of Jim's "5 Rules for Trimming Your Winning Stock Positions."

Weekly Roundup

Markets face rocky week as trade wars flare up and talks appear to falter.

Amgen To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

Amgen To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

THOUSAND OAKS, Calif. , May 10, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch 2019 Health Care Conference at 10 a.

Last Week's Portfolio Changes

We updated four price targets and two ratings last week.

Amgen To Highlight Extensive Long-Term Safety And Efficacy Data Of Aimovig® (erenumab-aooe) Across The Spectrum Of Migraine At AAN Annual Meeting

Amgen To Highlight Extensive Long-Term Safety And Efficacy Data Of Aimovig® (erenumab-aooe) Across The Spectrum Of Migraine At AAN Annual Meeting

After Long-Term Aimovig Treatment, Two-Thirds of Chronic Migraine Patients Converted to Episodic Migraine, Experiencing 11 Fewer Migraine Days per Month on Average

Amgen And Syapse Enter Precision Medicine Collaboration In Oncology

Amgen And Syapse Enter Precision Medicine Collaboration In Oncology

Supports Providers With Advanced Insight Tools and Research Opportunities

Teva Pharmaceuticals CEO: Stock on Track for 2020 Turnaround

Teva Pharmaceuticals CEO: Stock on Track for 2020 Turnaround

But is a Teva turnaround still coming after the stock's 70% loss in the past five years?

Real Money Post-Industrial Average Leaves Major Indices in the Dust

Real Money Post-Industrial Average Leaves Major Indices in the Dust

RMPIA outperformed once gain during April.

Amgen Ignites A Social Fitness Movement To Support The Fight Against Heart Disease And Cancer

Amgen Ignites A Social Fitness Movement To Support The Fight Against Heart Disease And Cancer

Amgen Breakaway Challenge Turns Walking, Running or Cycling Miles Into Support for Eight Independent Nonprofit Advocacy Organizations

Video: Jim's Daily Rundown for Wednesday

Jim discusses earnings from Apple, CVS, and Amgen and speaks to the up-and-down pattern he has seen this earnings season.

Amgen's First-Quarter Earnings Slump as Expenses Jump

Amgen's First-Quarter Earnings Slump as Expenses Jump

Adjusted earnings of $3.56 a share in the quarter topped analysts' expectations.

Amgen Reports First Quarter 2019 Financial Results

Amgen Reports First Quarter 2019 Financial Results

THOUSAND OAKS, Calif., April 30, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2019.

Video: Jim's Daily Rundown for Tuesday

Jim updates our plan for Anadarko Petroleum, expresses his discontent with Alphabet's quarter but provides input on what needs to change, discusses BP's earnings release, and shares his thoughts on Amgen and Apple ahead of tonight's earnings!

Google, Apple, AMD, General Electric and General Motors - 5 Things You Must Know

Google, Apple, AMD, General Electric and General Motors - 5 Things You Must Know

U.S. stock futures are mixed after Alphabet posts its weakest revenue gains since 2016; Apple, Advanced Micro Devices, General Electric and General Motors report earnings; BP's first-quarter profit tops forecasts.

Stalking an Entry in Pioneer Natural Resources Into Earnings

Stalking an Entry in Pioneer Natural Resources Into Earnings

Plus a possible setup in Amgen as earnings approach.

Weekly Roundup

Heavy earnings week and strong GDP push stocks higher.

Amgen Announces Webcast Of 2019 First Quarter Financial Results

Amgen Announces Webcast Of 2019 First Quarter Financial Results

THOUSAND OAKS, Calif., April 25, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Tuesday, April 30, 2019, after the close of the U.

Amgen: This Beaten Down Blue Chip Is Priced To Own

Amgen: This Beaten Down Blue Chip Is Priced To Own

As the healthcare sector sells off, it's time to look for attractive value. You don't have to go any further than Amgen.

Weekly Roundup

Markets see flat trading for first week of earnings season.

Amgen Foundation Launches Amgen Biotech Experience In Tampa, Florida

Amgen Foundation Launches Amgen Biotech Experience In Tampa, Florida

Long-Established Science Education Program to Give Local Secondary School Students Hands-On Biotechnology Lab Experience

TheStreet Quant Rating: B (Buy)